IV Compounding Service

Outcome
Defined

Outcome
Delivered

Reduce medication expense from 503Bs and OR medication waste

$1.6M

Annual savings from reduced outsourcing and OR drug waste

Improve supply chain control and medication availability for patient care

Zero

Stockouts of Heparin during a national shortage

Enhance patient safety through IV compounding accuracy and sterility

70%

Higher average monthly CSP production